NASDAQ:GRAL Grail (GRAL) Stock Price, News & Analysis $34.49 -2.32 (-6.30%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Grail Stock (NASDAQ:GRAL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Grail alerts:Sign Up Key Stats Today's Range$33.13▼$35.1750-Day Range$21.39▼$45.3052-Week Range$12.33▼$63.99Volume1.02 million shsAverage Volume1.22 million shsMarket Capitalization$1.22 billionP/E RatioN/ADividend YieldN/APrice Target$26.00Consensus RatingHold Company OverviewGRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.Read More… Grail Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks13th Percentile Overall ScoreGRAL MarketRank™: Grail scored higher than 13% of companies evaluated by MarketBeat, and ranked 876th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.1 / 5Analyst RatingHold Consensus RatingGrail has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageGrail has only been the subject of 2 research reports in the past 90 days.Read more about Grail's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Grail are expected to grow in the coming year, from ($15.15) to ($12.95) per share.Read more about Grail's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted18.78% of the float of Grail has been sold short.Short Interest Ratio / Days to CoverGrail has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Grail has recently increased by 11.85%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGrail does not currently pay a dividend.Dividend GrowthGrail does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted18.78% of the float of Grail has been sold short.Short Interest Ratio / Days to CoverGrail has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Grail has recently increased by 11.85%, indicating that investor sentiment is decreasing significantly. News and Social Media2.7 / 5News Sentiment0.95 News SentimentGrail has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Grail this week, compared to 6 articles on an average week.Search InterestOnly 14 people have searched for GRAL on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days.MarketBeat Follows13 people have added Grail to their MarketBeat watchlist in the last 30 days. This is an increase of 550% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Grail insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $360,436.00 in company stock.Read more about Grail's insider trading history. Receive GRAL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Grail and its competitors with MarketBeat's FREE daily newsletter. Email Address GRAL Stock News HeadlinesWhy GRAIL, Inc. (GRAL) is Surging in 2025April 30 at 8:27 PM | msn.comSkyrim-Like RPG Tainted Grail: The Fall of Avalon Announces Release DateApril 29 at 9:37 PM | msn.com"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside and write a book about it. This isn't just another Bitcoin prediction – it's a complete roadmap for what I believe will be the biggest wealth-building opportunity of this decade. The evidence is so compelling, I'm doing something that probably seems insane: I'm giving away my entire book for free. April 30, 2025 | Crypto 101 Media (Ad)GRAIL to Announce First Quarter 2025 Financial ResultsApril 29 at 4:01 PM | prnewswire.comGRAIL Inc.April 27 at 11:45 PM | barrons.comGRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual MeetingApril 22, 2025 | prnewswire.comThis Cancer Test Could Become Routine—and a Big Seller, Says AnalystApril 21, 2025 | barrons.comCanaccord starts Grail with a Buy, sees ‘solid upside’April 21, 2025 | markets.businessinsider.comSee More Headlines GRAL Stock Analysis - Frequently Asked Questions How have GRAL shares performed this year? Grail's stock was trading at $17.85 on January 1st, 2025. Since then, GRAL shares have increased by 93.2% and is now trading at $34.49. View the best growth stocks for 2025 here. How were Grail's earnings last quarter? Grail, Inc. (NASDAQ:GRAL) posted its quarterly earnings results on Thursday, February, 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business earned $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. Read the conference call transcript. Who are Grail's major shareholders? Top institutional shareholders of Grail include Wealthquest Corp (2.02%), Bank of New York Mellon Corp (0.92%), 180 Wealth Advisors LLC (0.30%) and Alpha Wealth Funds LLC (0.12%). Insiders that own company stock include Chun R Ding, Robert P Ragusa, Joshua J Ofman and Aaron Freidin. View institutional ownership trends. How do I buy shares of Grail? Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Grail own? Based on aggregate information from My MarketBeat watchlists, some other companies that Grail investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V). Company Calendar Last Earnings2/20/2025Today4/30/2025Next Earnings (Estimated)5/15/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:GRAL Previous SymbolNASDAQ:GRAL CIK1699031 WebN/A Phone(650) 771-9796FaxN/AEmployees1,360Year FoundedN/APrice Target and Rating Average Stock Price Target$26.00 High Stock Price Target$32.00 Low Stock Price Target$20.00 Potential Upside/Downside-24.6%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio9.65 Quick Ratio9.65 Sales & Book Value Annual Sales$125.60 million Price / Sales9.69 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares35,297,000Free FloatN/AMarket Cap$1.22 billion OptionableOptionable BetaN/A The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:GRAL) was last updated on 4/30/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.